Kodiak Sciences Inc (KOD)
9.12
+0.50
(+5.80%)
USD |
NASDAQ |
Jan 03, 16:00
9.13
+0.01
(+0.11%)
After-Hours: 20:00
Kodiak Sciences Enterprise Value: 282.07M for Jan. 3, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Pfizer Inc | 207.62B |
| Regeneron Pharmaceuticals Inc | 71.10B |
| Revance Therapeutics Inc | 571.26M |
| Editas Medicine Inc | -154.47M |
| Arcutis Biotherapeutics Inc | 1.585B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -43.95M |
| Total Expenses (Quarterly) | 46.63M |
| EPS Diluted (Quarterly) | -0.84 |
| Earnings Yield | -40.02% |